(Q46385504)

21 December 2017

title

Immunotherapy for Australia-antigen-associated hepatoma (English)

1 reference

21 December 2017

0 references

1 reference

J F Ziegenfuss

1

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 June 1973

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

1

1 reference

21 December 2017

page(s)

1365-1366

1 reference

21 December 2017

issue

7816

1 reference

21 December 2017

A "NEW" ANTIGEN IN LEUKEMIA SERA

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Association between lepromatous leprosy and Australia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Australia antigen as a hepatitis virus. Variation in host response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Endemia of Australia (SH) antigen-positive hepatitis in a dialysis center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Four cases of periarteritis nodosa associated with persistant Australia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Australia antigen in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

RNA of Australia Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Susceptibility to disease states.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Australia Antigen and Antibody in Transfused Children with Thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Biological Sciences: Association of Antibodies to Australia Antigen with Anti-Gm Antibodies in Italian Patients with Thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Serum Atypical Pseudocholinesterase and Genetic Factors in Leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

H.A.A. in primary liver-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Primary hepatoma and hepatitis-associated antigen in a young white woman.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Hepatoma and hepatitis-associated antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Occurrence of alpha‐fetoprotein in acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Lymphocyte Transformation and Hepatitis II. Lack of Direct in Vitro Inhibition by Purified Australia Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Transformation of human lymphocytes: inhibition by homologous alpha globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Prevention of cell-to-cell spread of herpes simplex virus by leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

In vitro stimulation of lymphocytes of HB antibody carriers by HB antigen (Australia antigen)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

Antibodies against Australiantigen in laboratory personnel.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2873%2991681-4

7 January 2021

10.1016/S0140-6736(73)91681-4

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

4122747

1 reference

21 December 2017